batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Kumquat’s KRAS blocker tempts Bayer 12 August 2025 Keytruda and Padcev make early bladder cancer bid 12 August 2025 Novartis scores a Vayhit, but filing some way off 12 August 2025 Tricky mechanisms fall by the wayside 11 August 2025 Epkinly bucks the delay trend 11 August 2025 Arcus reaches the end of the road for etrumadenant 7 August 2025 Jazz gets its Chimerix approval 7 August 2025 Lava engulfed by Xoma 5 August 2025 Load More